Perspective and challenges of mycorrhizal symbiosis in orchid medicinal plants

IF 4.7 4区医学 Q1 CHEMISTRY, MEDICINAL

Chinese Herbal Medicines Pub Date : 2024-04-01 DOI:10.1016/j.chmed.2024.03.001

Chunyan Leng, Mengyan Hou, Yongmei Xing, Juan Chen

{"title":"Perspective and challenges of mycorrhizal symbiosis in orchid medicinal plants","authors":"Chunyan Leng, Mengyan Hou, Yongmei Xing, Juan Chen","doi":"10.1016/j.chmed.2024.03.001","DOIUrl":null,"url":null,"abstract":"<div><p>The family Orchidaceae is of the most diverse taxon in the plant kingdom, and most of its members are highly valuable herbal medicines. Orchids have a unique mycorrhizal symbiotic relationship with specific fungi for carbohydrate and nutrient supplies in their whole lifecycle. The large-scale cultivation of the medicinal plant <em>Gastodia elata</em> is a successful example of using mycorrhizal symbiotic technology. In this review, we adopted <em>G. elata</em> and <em>Dendrobium officinale</em> as examples to describe the characteristics of orchid mycorrhiza and mycorrhizal benefits for host plants’ growth and health (e.g. biotic and abiotic stress and secondary metabolite accumulation). The challenges in applying mycorrhizal technology to the cultivation of orchid medicinal plants in the future were also discussed. This review aims to serve as a theoretical guide for the cultivation of mycorrhizal technology in medicinal orchid plants.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 2","pages":"Pages 172-179"},"PeriodicalIF":4.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638424000133/pdfft?md5=1cc06da6f5ba4728bbb6777687d09e30&pid=1-s2.0-S1674638424000133-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Herbal Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1674638424000133","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

Abstract

The family Orchidaceae is of the most diverse taxon in the plant kingdom, and most of its members are highly valuable herbal medicines. Orchids have a unique mycorrhizal symbiotic relationship with specific fungi for carbohydrate and nutrient supplies in their whole lifecycle. The large-scale cultivation of the medicinal plant Gastodia elata is a successful example of using mycorrhizal symbiotic technology. In this review, we adopted G. elata and Dendrobium officinale as examples to describe the characteristics of orchid mycorrhiza and mycorrhizal benefits for host plants’ growth and health (e.g. biotic and abiotic stress and secondary metabolite accumulation). The challenges in applying mycorrhizal technology to the cultivation of orchid medicinal plants in the future were also discussed. This review aims to serve as a theoretical guide for the cultivation of mycorrhizal technology in medicinal orchid plants.

查看原文本刊更多论文

兰科药用植物菌根共生的前景与挑战

兰科是植物王国中种类最繁多的类群，其大多数成员都是非常珍贵的中药材。兰花在其整个生命周期中与特定真菌建立了独特的菌根共生关系，以获得碳水化合物和养分供应。药用植物 Gastodia elata 的大规模种植是利用菌根共生技术的一个成功范例。在这篇综述中，我们以 G. elata 和 Dendrobium officinale 为例，阐述了兰科植物菌根的特点以及菌根对寄主植物生长和健康的益处（如生物和非生物胁迫以及次生代谢物的积累）。此外，还讨论了未来将菌根技术应用于兰科药用植物栽培所面临的挑战。本综述旨在为兰科药用植物菌根技术的栽培提供理论指导。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chinese Herbal Medicines CHEMISTRY, MEDICINAL-

CiteScore

4.40

自引率

5.30%

发文量

629

审稿时长

10 weeks

期刊介绍： Chinese Herbal Medicines is intended to disseminate the latest developments and research progress in traditional and herbal medical sciences to researchers, practitioners, academics and administrators worldwide in the field of traditional and herbal medicines. The journal's international coverage ensures that research and progress from all regions of the world are widely included. CHM is a core journal of Chinese science and technology. The journal entered into the ESCI database in 2017, and then was included in PMC, Scopus and other important international search systems. In 2019, CHM was successfully selected for the “China Science and Technology Journal Excellence Action Plan” project, which has markedly improved its international influence and industry popularity. CHM obtained the first impact factor of 3.8 in Journal Citation Reports (JCR) in 2023.